Inhalatn Scieiences AB signed a new R&D contract worth 257,000 SEK for Inhalation Research Services (IRS) work for a returning, long-standing customer - a major branded generic pharma company. A long-standing customer of ISAB's research services and instruments is outsourcing research and development work worth 257,000 SEK to ISAB during a peak in their development activities. The work will be carried out using ISAB's flexible, multi-modular PreciseInhale aerosol generation system that enables precision dosing of a range of in vitro and in vivo exposure modules.